Orchestra BioMed appoints Andrew Taylor as CFO, succeeding Kaswan
- Orchestra BioMed Holdings (NASDAQ:OBIO) has announced the appointment of Bill Little as EVP of Corporate Development and Strategy and Andrew Taylor as CFO.
- Mr. Taylor succeeds former CFO Michael Kaswan, who will continue as a consultant to the Company during a transition period.
- The appointment of Mr. Little marks the establishment of a formal corporate development function within Orchestra BioMed focused on driving strategy for additional potential strategic collaborations and pipeline expansion.